Ligand validation:2F1O

FAD: FLAVIN-ADENINE DINUCLEOTIDE

FAD is a Ligand Of Interest in 2F1O designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2F1O_FAD_E_4301	62%	0%	0.143	0.934	12.88	2.51	13	13	2	0	100%	1
2F1O_FAD_C_2301	57%	0%	0.15	0.924	12.26	2.42	16	12	6	0	100%	1
2F1O_FAD_B_1301	54%	0%	0.16	0.924	12.17	2.46	16	13	5	0	100%	1
2F1O_FAD_G_6301	53%	0%	0.161	0.923	11.57	2.46	18	13	2	0	100%	1
2F1O_FAD_D_3301	53%	0%	0.163	0.923	12.04	2.43	16	14	4	0	100%	1
2F1O_FAD_F_5301	51%	0%	0.159	0.913	11.82	2.44	17	12	2	0	100%	1
2F1O_FAD_A_301	43%	0%	0.174	0.897	11.67	2.48	18	13	4	0	100%	1
2F1O_FAD_H_7301	37%	0%	0.177	0.874	11.42	2.48	15	10	5	0	100%	1
8OK0_FAD_A_301	95%	62%	0.064	0.968	0.66	0.79	-	1	1	0	100%	1
5FUQ_FAD_B_1274	88%	3%	0.088	0.965	3.76	2.25	17	14	1	0	100%	1
5EA2_FAD_G_301	87%	70%	0.088	0.959	0.49	0.65	-	1	0	0	100%	1
5A4K_FAD_C_1274	80%	35%	0.105	0.953	1.28	1.29	5	9	3	0	100%	1
4CET_FAD_A_1225	77%	33%	0.115	0.953	1.32	1.31	5	10	1	0	100%	1
4KGD_FAD_B_701	100%	45%	0.031	0.997	1.1	1.03	2	2	0	0	100%	1
4PVH_FAD_A_601	100%	35%	0.028	0.993	1.32	1.23	7	7	2	0	100%	1
4PVK_FAD_A_601	100%	43%	0.026	0.995	1.12	1.07	4	2	0	0	100%	1
4FEG_FAD_B_710	100%	38%	0.033	0.997	1.25	1.2	4	5	1	0	100%	1
4FEE_FAD_B_701	100%	40%	0.034	0.996	1.15	1.17	3	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.